These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34692498)

  • 21. A Machine Learning Method to Trace Cancer Primary Lesion Using Microarray-Based Gene Expression Data.
    Lu Q; Chen F; Li Q; Chen L; Tong L; Tian G; Zhou X
    Front Oncol; 2022; 12():832567. PubMed ID: 35530331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of Transcriptome-Based Gene Set Featurization for Machine Learning Model to Predict the Origin of Metastatic Cancer.
    Jeong Y; Chu J; Kang J; Baek S; Lee JH; Jung DS; Kim WW; Kim YR; Kang J; Do IG
    Curr Issues Mol Biol; 2024 Jul; 46(7):7291-7302. PubMed ID: 39057073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Tumor Tissue of Origin with RNA-Seq Data and Using Gradient Boosting Strategy.
    Li R; Liao B; Wang B; Dai C; Liang X; Tian G; Wu F
    Biomed Res Int; 2021; 2021():6653793. PubMed ID: 33681364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integrated tool for determining the primary origin site of metastatic tumours.
    Santos MTD; Souza BF; Cárcano FM; Vidal RO; Scapulatempo-Neto C; Viana CR; Carvalho AL
    J Clin Pathol; 2018 Jul; 71(7):584-593. PubMed ID: 29248889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Clinical Validation of a 90-Gene Expression Assay for Identifying Tumor Tissue Origin.
    Ye Q; Wang Q; Qi P; Chen J; Sun Y; Jin S; Ren W; Chen C; Liu M; Xu M; Ji G; Yang J; Nie L; Xu Q; Huang D; Du X; Zhou X
    J Mol Diagn; 2020 Sep; 22(9):1139-1150. PubMed ID: 32610162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.
    Hainsworth JD; Schnabel CA; Erlander MG; Haines DW; Greco FA
    Clin Colorectal Cancer; 2012 Jun; 11(2):112-8. PubMed ID: 22000811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis.
    Al Assaad M; Shin N; Sigouros M; Manohar J; Antysheva Z; Kotlov N; Kiriy D; Nikitina A; Kleimenov M; Tsareva A; Makarova A; Fomchenkova V; Dubinina J; Boyko A; Almog N; Wilkes D; Escalon JG; Saxena A; Elemento O; Sternberg CN; Nanus DM; Mosquera JM
    Front Oncol; 2023; 13():1274163. PubMed ID: 38318324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Tissue Origin Identification for Cancer of Unknown Primary: Gene Expression Profiling Approach.
    Pu X; Yang S; Xu Y; Chen B; Wang Q; Gong Q; Wu L
    Front Oncol; 2021; 11():702887. PubMed ID: 34858803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics).
    Vibert J; Pierron G; Benoist C; Gruel N; Guillemot D; Vincent-Salomon A; Le Tourneau C; Livartowski A; Mariani O; Baulande S; Bidard FC; Delattre O; Waterfall JJ; Watson S
    J Mol Diagn; 2021 Oct; 23(10):1380-1392. PubMed ID: 34325056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnosis and treatment for a patient with cancer of unknown primary: A case report.
    Hu H; Pan Q; Shen J; Yao J; Fu G; Tian F; Yan N; Han W
    Front Genet; 2023; 14():1085549. PubMed ID: 36741314
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.
    Pentheroudakis G; Greco FA; Pavlidis N
    Cancer Treat Rev; 2009 May; 35(3):221-7. PubMed ID: 19046817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay.
    Ma XJ; Patel R; Wang X; Salunga R; Murage J; Desai R; Tuggle JT; Wang W; Chu S; Stecker K; Raja R; Robin H; Moore M; Baunoch D; Sgroi D; Erlander M
    Arch Pathol Lab Med; 2006 Apr; 130(4):465-73. PubMed ID: 16594740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and therapeutic management of cancer of an unknown primary.
    Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
    Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
    Varadhachary GR; Talantov D; Raber MN; Meng C; Hess KR; Jatkoe T; Lenzi R; Spigel DR; Wang Y; Greco FA; Abbruzzese JL; Hainsworth JD
    J Clin Oncol; 2008 Sep; 26(27):4442-8. PubMed ID: 18802157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Genetic Technologies in Diagnosis and Treatment of Cancer of Unknown Primary.
    Krawczyk P; Jassem J; Wojas-Krawczyk K; Krzakowski M; Dziadziuszko R; Olszewski W
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.
    Karapetis CS; Guccione L; Tattersall MH; Gooden H; Vajdic CM; Lambert S; Robotin M; Mileshkin L; Schofield P
    Intern Med J; 2017 Apr; 47(4):408-414. PubMed ID: 28101916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patients.
    Moon I; LoPiccolo J; Baca SC; Sholl LM; Kehl KL; Hassett MJ; Liu D; Schrag D; Gusev A
    Res Sq; 2023 Jan; ():. PubMed ID: 36711812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.
    Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
    J Natl Cancer Inst; 2013 Jun; 105(11):782-90. PubMed ID: 23641043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer of unknown primary with EGFR mutation successfully treated with targeted therapy directed by clinical next-generation sequencing: a case report.
    Mitani Y; Kanai M; Kou T; Kataoka S; Doi K; Matsubara J; Ohashi S; Matsumoto S; Muto M
    BMC Cancer; 2020 Dec; 20(1):1177. PubMed ID: 33267781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
    Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
    Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.